159 related articles for article (PubMed ID: 17934388)
1. Neuroprotection: a new strategy in the treatment of schizophrenia. Neurobiological basis of neurodegeneration and neuroprotection.
Lieberman JA
CNS Spectr; 2007 Oct; 12(10 Suppl 18):4-6. PubMed ID: 17934388
[No Abstract] [Full Text] [Related]
2. Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis.
Buckley PF
CNS Spectr; 2007 Oct; 12(10 Suppl 18):7-10. PubMed ID: 19322958
[No Abstract] [Full Text] [Related]
3. Neuroprotection: a new strategy in the treatment of schizophrenia. Early detection and intervention.
Perkins DO
CNS Spectr; 2007 Oct; 12(10 Suppl 18):10-3. PubMed ID: 19322959
[No Abstract] [Full Text] [Related]
4. Do glutamatergic agents represent a new class of antidepressant drugs? Part 1.
Sanacora G
J Clin Psychiatry; 2009 Oct; 70(10):1473-5. PubMed ID: 19906350
[No Abstract] [Full Text] [Related]
5. Neurofunctional view of psychiatry: clinical brain imaging revisited.
Hendler T; Bleich-Cohen M; Sharon H
Curr Opin Psychiatry; 2009 May; 22(3):300-5. PubMed ID: 19346947
[TBL] [Abstract][Full Text] [Related]
6. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
[TBL] [Abstract][Full Text] [Related]
7. Editor review of "Erythropoietin as a neuroprotective agent in traumatic brain injury" by Mammis et al.
Ausman JI
Surg Neurol; 2009 May; 71(5):525. PubMed ID: 19386291
[No Abstract] [Full Text] [Related]
8. Delayed combinatorial treatment with flavopiridol and minocycline provides longer term protection for neuronal soma but not dendrites following global ischemia.
Iyirhiaro GO; Brust TB; Rashidian J; Galehdar Z; Osman A; Phillips M; Slack RS; Macvicar BA; Park DS
J Neurochem; 2008 May; 105(3):703-13. PubMed ID: 18205749
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes.
Kaindl AM; Sifringer M; Koppelstaetter A; Genz K; Loeber R; Boerner C; Stuwe J; Klose J; Felderhoff-Mueser U
Ann Neurol; 2008 Nov; 64(5):523-34. PubMed ID: 19067366
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil.
Takada-Takatori Y; Kume T; Ohgi Y; Izumi Y; Niidome T; Fujii T; Sugimoto H; Akaike A
J Neurosci Res; 2008 Dec; 86(16):3575-83. PubMed ID: 18655200
[TBL] [Abstract][Full Text] [Related]
11. Linkage between immunomodulation, neuroprotection and neurogenesis.
Aharoni R; Arnon R
Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin as a neuroprotective agent in traumatic brain injury Review.
Mammis A; McIntosh TK; Maniker AH
Surg Neurol; 2009 May; 71(5):527-31; discussion 531. PubMed ID: 18789503
[TBL] [Abstract][Full Text] [Related]
13. Lost in translation: again, another failed neuroprotection trial.
Brew BJ
Neurology; 2007 Sep; 69(13):1308-9. PubMed ID: 17893290
[No Abstract] [Full Text] [Related]
14. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias.
Brenner SR
Neurology; 2005 Jun; 64(11):1991; author reply 1991. PubMed ID: 15955973
[No Abstract] [Full Text] [Related]
15. Erythropoietin: novel approaches to neuroprotection in human brain disease.
Ehrenreich H; Aust C; Krampe H; Jahn H; Jacob S; Herrmann M; Sirén AL
Metab Brain Dis; 2004 Dec; 19(3-4):195-206. PubMed ID: 15554415
[TBL] [Abstract][Full Text] [Related]
16. Effects of activated protein C on neonatal hypoxic ischemic brain injury.
Yesilirmak DC; Kumral A; Tugyan K; Cilaker S; Baskin H; Yilmaz O; Duman N; Ozkan H
Brain Res; 2008 May; 1210():56-62. PubMed ID: 18420181
[TBL] [Abstract][Full Text] [Related]
17. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro.
Mu X; He G; Cheng Y; Li X; Xu B; Du G
Pharmacol Biochem Behav; 2009 Jun; 92(4):642-8. PubMed ID: 19327378
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: what have we learned?
Karceski S
Neurology; 2007 Feb; 68(9):E9-10. PubMed ID: 17325266
[No Abstract] [Full Text] [Related]
19. Rasagiline in neurodegeneration.
Schapira AH
Exp Neurol; 2008 Aug; 212(2):255-7. PubMed ID: 18571162
[No Abstract] [Full Text] [Related]
20. Brain imaging in schizophrenia.
Hirayasu Y
Neuropathology; 2007 Dec; 27(6):601-3. PubMed ID: 18021383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
